Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Under the brand name Ozmepic, it's approved to treat type 2 diabetes, while under the brand name Wegovy, it's approved for weight loss
How it Supports Fat Loss and Muscle Growth One of the biggest reasons people use this peptide combo is for fat loss
Target Pathway Differences AOD-9604s proposed mechanism centers on direct lipolytic activity, theorized to break down stored fat independent of hormonal signaling cascades
Key Takeaways: GLP-1 vs GIP Both are incretin hormones released by your intestines after eating GLP-1 primarily affects appetite, gastric emptying, and insulin secretion GIP influences insulin secretion, glucagon regulation, and fat metabolism Single GLP-1 agonists (semaglutide) produce 14.9% average weight loss Dual GLP-1/GIP agonists (tirzepatide) produce 22.5% average weight loss The dual action appears to create additive rather than merely overlapping effects Both receptor types play important roles in metabolic regulation Understanding the difference helps explain why tirzepatide shows superior results What Are Incretin Hormones
